The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis
Abstract
BACKGROUND: This study was undertaken to determine outcomes of stereotactic body radiotherapy for colorectal liver metastases in a pooled patient cohort. METHODS: Patients with colorectal liver metastases from 3 institutions were included if they had 1 to 4 lesions, received 1 to 6 fractions of stereotactic body radiotherapy, and had radiologic imaging ≥3 months post‐treatment. Sixty‐five patients with 102 lesions treated from August 2003 to May 2009 were retrospectively analyzed. A tumor control probability (TCP) model was used to estimate the 3‐fraction dose required for >90% local control after converting the schedule into biologically equivalent dose (BED), single‐fraction equivalent dose, or linear quadratic model‐based single‐fraction dose. RESULTS: Forty‐seven (72%) patients had ≥1 chemotherapy regimen before stereotactic body radiotherapy, and 27 (42%) patients had ≥2 regimens. The median follow‐up was 1.2 years (range, 0.3‐5.2 years). The median dose was 42 gray (Gy; range, 22‐60 Gy). When evaluated separately by multivariate analysis, total dose (P = .0015), dose/fraction (P = .003), and BED (P = .004) all correlated with local control by lesion. On multivariate analysis, nonactive extrahepatic disease was associated with overall survival (OS; P = .046), and sustained local control was closely correlated (P = .06). By using single‐fraction equivalent dose, BED, or linear quadratic model‐based single‐fraction dose in the TCP model, the estimated dose range needed for 1‐year local control >90% is 46 to 52 Gy in 3 fractions. CONCLUSIONS: Liver stereotactic body radiotherapy is well tolerated and effective for colorectal liver metastases. The strong correlation between local control and OS supports controlling hepatic disease even for heavily pretreated patients. For a 3‐fraction regimen of stereotactic body radiotherapy, a prescription dose of ≥48 Gy should be considered, if normal tissue constraints allow. Cancer 2011. © 2011 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
Timmerman, R. (2010) · JAMA · doi:10.1001/jama.2010.261 · Cited by 2,532
Spiess, P. E., Lee, A. K., Leibovici, D., Wang, X., Do, K., & Pisters, L. L. (2006) · Cancer · doi:10.1002/cncr.21979 · Cited by 1,930
Adam, R., Delvart, V., Pascal, G., Valeanu, A., Castaing, D., Azoulay, D., Giacchetti, S., Paule, B., Kunstlinger, F., Ghémard, O., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000141198.92114.f6 · Cited by 1,480
The stereotaxic method and radiosurgery of the brain.
Leksell, L. G. (1951) · PubMed · Cited by 1,408
Liver resection for colorectal metastases.
Fong, Y., Cohen, A. M., Fortner, J. G., Enker, W. E., Turnbull, A. D., Coit, D. G., Marrero, A. M., Prasad, M., Blumgart, L. H., & Brennan, M. F. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.938 · Cited by 1,284
Complication Probability as Assessed from Dose-Volume Histograms
Lyman, J. T. (1985) · Radiation Research · doi:10.2307/3576626 · Cited by 1,160
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
Rusthoven, K. E., Kavanagh, B. D., Burri, S. H., Chen, C., Cardenes, H., Chidel, M. A., Pugh, T. J., Kane, M., Gaspar, L. E., & Schefter, T. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6386 · Cited by 1,082
Self-citationKemeny, N., Huang, Y., Cohen, A. M., Shi, W., Conti, J. A., Brennan, M. F., Bertino, J. R., Turnbull, A. D. M., Sullivan, D., Stockman, J., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412702 · Cited by 957
Kutcher, G. J., & Burman, C. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90972-3 · Cited by 912
Onishi, H., Araki, T., Shirato, H., Nagata, Y., Hiraoka, M., Gomi, K., Yamashita, T., Niibe, Y., Karasawa, K., Hayakawa, K., et al. (2004) · Cancer · doi:10.1002/cncr.20539 · Cited by 891
Solbiati, L., Livraghi, T., Goldberg, S. N., Ierace, T., Meloni, F., Dellanoce, M., Cova, L., Halpern, E. F., & Gazelle, G. S. (2001) · Radiology · doi:10.1148/radiol.2211001624 · Cited by 870
Fuchs, C. S., Marshall, J., Mitchell, E., Wierzbicki, R., Ganju, V., Jeffery, M., Schulz, J., Richards, D., Soufi-Mahjoubi, R., Wang, B., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3357 · Cited by 851
Hecht, J. R., Mitchell, E., Chidiac, T., Scroggin, C., Hagenstad, C., Spigel, D., Marshall, J., Cohn, A., McCollum, D., Stella, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8135 · Cited by 850
Baumann, P., Nyman, J., Hoyer, M., Wennberg, B., Gagliardi, G., Lax, I., Drugge, N., Ekberg, L., Friesland, S., Johansson, K.-A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.5681 · Cited by 836
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
Rusthoven, K. E., Kavanagh, B. D., Cardenes, H., Stieber, V. W., Burri, S. H., Feigenberg, S. J., Chidel, M. A., Pugh, T. J., Franklin, W., Kane, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6329 · Cited by 805
Self-citationPark, C., Papiez, L., Zhang, S., Story, M., & Timmerman, R. D. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.10.059 · Cited by 651
Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?
Benoist, S., Brouquet, A., Penna, C., Julié, C., El Hajjam, M., Chagnon, S., Mitry, E., Rougier, P., & Nordlinger, B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8727 · Cited by 607
Complication Probability as Assessed from Dose-Volume Histograms
Lyman, J. T. (1985) · Radiation Research Supplement · doi:10.2307/3583506 · Cited by 535
Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases
Lee, M. T., Kim, J. J., Dinniwell, R., Brierley, J., Lockwood, G., Wong, R., Cummings, B., Ringash, J., Tse, R. V., Knox, J. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.0600 · Cited by 473
Self-citationPhase II study on stereotactic body radiotherapy of colorectal metastases
Hoyer, M., Roed, H., Traberg Hansen, A., Ohlhuis, L., Petersen, J., Nellemann, H., Kiil Berthelsen, A., Grau, C., Aage Engelholm, S., & Von Der Maase, H. (2006) · Acta Oncologica · doi:10.1080/02841860600904854 · Cited by 426
Hughes, K. S., Rosenstein, R. B., Songhorabodi, S., Adson, M. A., Ilstrup, D. M., Fortner, J. G., Maclean, B. J., Foster, J. H., Daly, J. M., Fitzherbert, D., et al. (1988) · Diseases of the Colon & Rectum · doi:10.1007/bf02552560 · Cited by 383
Livraghi, T., Solbiati, L., Meloni, F., Ierace, T., Goldberg, S. N., & Gazelle, G. S. (2003) · Cancer · doi:10.1002/cncr.11426 · Cited by 329
Dose-Escalation Study of Single-Fraction Stereotactic Body Radiotherapy for Liver Malignancies
Goodman, K. A., Wiegner, E. A., Maturen, K. E., Zhang, Z., Mo, Q., Yang, G., Gibbs, I. C., Fisher, G. A., & Koong, A. C. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.020 · Cited by 323
Self-citationDunlap, N. E., Cai, J., Biedermann, G. B., Yang, W., Benedict, S. H., Sheng, K., Schefter, T. E., Kavanagh, B. D., & Larner, J. M. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.027 · Cited by 276
Self-citationStereotactic radiotherapy of primary liver cancer and hepatic metastases
Wulf, J., Guckenberger, M., Haedinger, U., Oppitz, U., Mueller, G., Baier, K., & Flentje, M. (2006) · Acta Oncologica · doi:10.1080/02841860600904821 · Cited by 271
Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases
Katz, A. W., Carey-Sampson, M., Muhs, A. G., Milano, M. T., Schell, M. C., & Okunieff, P. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.10.025 · Cited by 232
Pettersson, N., Nyman, J., & Johansson, K.-A. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.03.022 · Cited by 169
Otto, G., Düber, C., Hoppe‐Lotichius, M., König, J., Heise, M., & Pitton, M. B. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181bc9fae · Cited by 159
Rivoire, M. L., Cian, F. D., Méeus, P., Négrier, S., Sebban, H., & Kaemmerlen, P. (2002) · Cancer · doi:10.1002/cncr.10973 · Cited by 129
Management of liver metastases from colorectal cancer.
Kemeny, N. E. (2006) · PubMed · Cited by 120
Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease
Carpizo, D. R., & D'Angelica, M. I. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70081-6 · Cited by 117
Liver metastases from colorectal cancer: radioembolization with systemic therapy
Nicolay, N. H., Berry, D. P., & Sharma, R. A. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.165 · Cited by 97
Oligometastases confined one organ from colorectal cancer treated by SBRT
Kang, J.-K., Kim, M., Kim, J. H., Yoo, S. Y., Cho, C. K., Yang, K., Yoo, H. J., Seo, Y. S., Lee, D. H., Kang, H. J., et al. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9325-0 · Cited by 83
Self-citationHotta, T., Takifuji, K., Arii, K., Yokoyama, S., Matsuda, K., Higashiguchi, T., Tominaga, T., Oku, Y., & Yamaue, H. (2006) · PubMed · Cited by 16
Cited by
Weickhardt, A. J., Scheier, B., Burke, J. M., Gan, G., Lu, X., Bunn, P. A., Aisner, D. L., Gaspar, L. E., Kavanagh, B. D., Doebele, R. C., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182745948 · Cited by 684
Self-citationRadiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation
Hellevik, T., & Martinez-Zubiaurre, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00001 · Cited by 442
Colorectal liver metastases: Current management and future perspectives
Martin, J., Petrillo, A., Smyth, E. C., Shaida, N., Khwaja, S., Cheow, H., Duckworth, A., Heister, P., Praseedom, R., Jah, A., et al. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i10.761 · Cited by 275
Metadata
- Authors
- Chang, D. T., Swaminath, A., Kozak, M., Weintraub, J., Koong, A. C., Kim, J., Dinniwell, R., Brierley, J., Kavanagh, B. D., Dawson, L. A., & Schefter, T. E.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2011-03-22
- Volume
- 117
- Issue
- 17
- Pages
- 4060-4069
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1501842160
- Cited by
- 302
- References
- 37
- FWCI
- 25.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.